Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

PSNL
Personalis, Inc. Common Stock
stock NASDAQ

At Close
May 9, 2025 3:59:45 PM EDT
5.05USD-2.132%(-0.11)788,397
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 9, 2025 8:40:30 AM EDT
5.16USD0.000%(0.00)820
After-hours
May 9, 2025 4:11:30 PM EDT
5.04USD-0.198%(-0.01)1,307
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 6, 2022
04:03PM EST  Personalis Sees Q4 Sales ~$20.7M Vs. $20.28M Est., FY21 Sales ~$85.5M Vs. $85.04M Est.   Benzinga
04:01PM EST  Personalis Reports Preliminary Fourth Quarter and Full Year 2021 Revenue   Business Wire
Dec 28, 2021
04:01PM EST  Personalis to Participate in the 24th Annual Needham Virtual Growth Conference   Business Wire
Nov 18, 2021
04:26PM EST  Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference   Business Wire
Nov 8, 2021
10:12AM EST  Personalis's Return On Capital Employed Insights   Benzinga
09:29AM EST  Morgan Stanley Downgrades Personalis to Equal-Weight, Lowers Price Target to $25   Benzinga
Nov 4, 2021
07:45AM EDT  Personalis Sees Q4 Sales $20.2M-$20.4M Vs. $20.39M Est., FY21 Sales ~$85M Vs. $85.01M Est.   Benzinga
07:44AM EDT  Personalis Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $22.30M Beat $22.24M Estimate   Benzinga
07:14AM EDT  Personalis Q3 Net Loss $17.7 Mln Vs. Net Loss $9.5 Mln Last Year   RTTNews
07:00AM EDT  Personalis Reports Third Quarter 2021 Financial Results   Business Wire
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Nov 3, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021   Benzinga
09:13AM EDT  Needham Downgrades Personalis to Hold   Benzinga
Oct 26, 2021
04:33PM EDT  Personalis Says Publishes New Data Demonstrating Performance, Utility Of SHERPA For High-Accuracy Neoantigen Prediction And Cancer Diagnostic Biomarker Development   Benzinga
Oct 21, 2021
09:00AM EDT  Personalis to Announce Third Quarter Financial Results on November 4, 2021   Business Wire
Oct 12, 2021
09:11AM EDT  Personalis Shares Spike Higher; Co Collaborates With Mayo Clinic To Expand Cancer Genomic Testing   Benzinga
Sep 20, 2021
11:58AM EDT  Needham Maintains Buy on Personalis, Lowers Price Target to $28   Benzinga
Aug 26, 2021
04:01PM EDT  Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference   Business Wire
Aug 20, 2021
02:36PM EDT  Return on Capital Employed Insights for Personalis   Benzinga
Aug 4, 2021
05:03PM EDT  Recap: Personalis Q2 Earnings   Benzinga
04:27PM EDT  Personalis Sees Q3 Sales ~$22.2M Vs. $22.16M Est., FY21 Sales ~$85M Vs. $85.23M   Benzinga
04:27PM EDT  Personalis Q2 EPS $(0.34) Beats $(0.39) Estimate, Sales $21.70M Beat $21.21M Estimate   Benzinga
04:01PM EDT  Personalis Reports Second Quarter 2021 Financial Results   Business Wire
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Aug 3, 2021
04:02PM EDT  Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference   Business Wire
Aug 2, 2021
04:38PM EDT  Personalis Highlights Publication Of Its Study 'Prediction of immunotherapy response in melanoma through combined modeling of neoantigen burden and immune-related resistance mechanisms' In Clinical Cancer Research Journal   Benzinga
04:17PM EDT  Personalis Highlights Study Titled 'Prediction of immunotherapy response in melanoma through combined modeling of neoantigen burden and immune-related resistance mechanisms,'   Benzinga
Jul 21, 2021
04:01PM EDT  Personalis to Announce Second Quarter Financial Results on August 4, 2021   Business Wire
May 18, 2021
04:01PM EDT  Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit   Business Wire
12:16PM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021   Benzinga
May 7, 2021
08:34AM EDT  Morgan Stanley Maintains Overweight on Personalis, Lowers Price Target to $35   Benzinga
May 6, 2021
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021   Benzinga
07:39AM EDT  Needham Maintains Buy on Personalis, Lowers Price Target to $33   Benzinga
06:37AM EDT  Oppenheimer Upgrades Personalis to Outperform, Announces $28 Price Target   Benzinga
May 5, 2021
04:10PM EDT  Personalis Sees Q2 Sales ~$21.3M Vs. $21.23M Est., FY21 Sales ~$85M Vs. $84.69M Est.   Benzinga
04:09PM EDT  Personalis Q1 EPS $(0.29) Beats $(0.36) Estimate, Sales $20.90M Beat $20.43M Estimate   Benzinga
04:01PM EDT  Personalis Reports First Quarter 2021 Financial Results   Business Wire
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
Apr 29, 2021
04:01PM EDT  Personalis to Present at the 2021 Bank of America Healthcare Conference   Business Wire
Apr 21, 2021
04:01PM EDT  Personalis to Report First Quarter 2021 Financial Results on May 5, 2021   Business Wire
Apr 8, 2021
04:08PM EDT  Personalis Says Presents Data At AACR Annual Meeting 2021 Showcasing Personalis ImmunoID NeXT Platform   Benzinga
Mar 29, 2021
04:03PM EDT  Personalis Reports Collab With MapKure To Use Co.'s NeXT Platform For Trials, Companion Diagnostic Development, No Terms Disclosed   Benzinga
Mar 1, 2021
09:24AM EST  Morgan Stanley Maintains Overweight on Personalis, Raises Price Target to $38   Benzinga
Feb 26, 2021
06:19AM EST  Needham Assumes Personalis at Buy, Announces Price Target of $38   Benzinga
Feb 25, 2021
04:25PM EST  Personalis Q4 EPS $(0.34) Misses $(0.29) Estimate, Sales $20.18M Beat $20.07M Estimate   Benzinga
04:02PM EST  Personalis Reports Fourth Quarter and Full Year 2020 Financial Results   Business Wire
04:03AM EST  Earnings Scheduled For February 25, 2021   Benzinga
Feb 22, 2021
08:48PM EST  CORRECTING and REPLACING Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021   Business Wire
Feb 17, 2021
09:04AM EST  Natera And Personalis Announce Personalized Oncology Partnership   Benzinga
09:03AM EST  Natera and Personalis Partner for Personalized Monitoring in Oncology   PR Newswire
Feb 16, 2021
04:02PM EST  Personalis to Present at Upcoming Investor Conferences   Business Wire
Feb 11, 2021
04:01PM EST  Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021   Business Wire
Feb 4, 2021
04:01PM EST  Personalis to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference   Business Wire
Jan 28, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2021   Benzinga
07:14AM EST  Truist Securities Initiates Coverage On Personalis with Buy Rating, Announces Price Target of $50   Benzinga
Jan 27, 2021
10:35AM EST  Personalis, Inc. (PSNL) shares are down on Wednesday morning trade. The company has announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at $38.00 per share. Currently, shares are at $38.41, down 9.56 percent from the previous close of $42.47 on a volume of 1,439,959.   RTTNews
Jan 26, 2021
10:51PM EST  Personalis Prices Public Offering Of 3.95 Mln Shares At $38/Shr   RTTNews
10:09PM EST  Personalis Announces Pricing of Public Offering of Common Stock   Business Wire
04:32PM EST  Personalis Reports $150M Common Stock Offering   Benzinga
04:31PM EST  Personalis Announces Launch of Public Offering of Common Stock   Business Wire
04:14PM EST  Personalis Filing Shows Registration For $150M Common Stock Offering   Benzinga
Jan 13, 2021
06:11AM EST  HC Wainwright & Co. Maintains Buy on Personalis, Raises Price Target to $50   Benzinga
Jan 11, 2021
04:04PM EST  Personalis Sees Prelim. Q4 Sales $20.2 vs $19.7M Est., Sees Prelim. FY20 Sales $78.6M vs $78.17M Est.   Benzinga
04:01PM EST  Personalis Reports Preliminary Fourth Quarter 2020 Revenue   Business Wire
Dec 30, 2020
04:37PM EST  Personalis S-3 Shows Registration For $300M Mixed Securities Shelf Offering; ~1.77M Shares Of Common Stock Will Be Offered By Selling Shareholders   Benzinga
Dec 28, 2020
04:01PM EST  Personalis to Present at the 23rd Annual Needham Virtual Growth Conference   Business Wire
Dec 17, 2020
09:12AM EST  Personalis Announces Launch Of NEOPS, A Neoantigen-Based Composite Biomarker For Cancer Immunotherapy Response   Benzinga
Nov 18, 2020
08:09AM EST  Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event Nov. 18-19   Benzinga
Nov 12, 2020
08:15AM EST  10 Biggest Price Target Changes For Thursday   Benzinga
06:36AM EST  Needham Maintains Buy on Personalis, Raises Price Target to $32   Benzinga
Nov 9, 2020
08:43AM EST  Morgan Stanley Maintains Overweight on Personalis, Raises Price Target to $27   Benzinga
Nov 6, 2020
10:57AM EST  Personalis shares are trading lower after the company reported Q3 earnings results. Oppenheimer also downgraded the stock from Outperform to Perform.   Benzinga
09:31AM EST  Benzinga's Top Upgrades, Downgrades For November 6, 2020   Benzinga
06:27AM EST  Oppenheimer Downgrades Personalis to Perform   Benzinga
Nov 5, 2020
04:11PM EST  Personalis Q3 EPS $(0.27) Beats $(0.28) Estimate, Sales $19.80M Beat $19.06M Estimate   Benzinga
04:01PM EST  Personalis Reports Third Quarter 2020 Financial Results   Business Wire
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Oct 27, 2020
04:01PM EDT  Personalis to Participate in Upcoming Investor Conferences   Business Wire
Oct 22, 2020
04:01PM EDT  Personalis to Announce Third Quarter 2020 Financial Results on November 5, 2020   Business Wire
Oct 19, 2020
09:57AM EDT  Citigroup Initiates Coverage On Personalis with Buy Rating, Announces Price Target of $35   Benzinga
Oct 8, 2020
10:00AM EDT  Benzinga's Top Upgrades, Downgrades For October 8, 2020   Benzinga
05:50AM EDT  BTIG Initiates Coverage On Personalis with Buy Rating, Announces Price Target of $35   Benzinga
Sep 2, 2020
04:02PM EDT  Personalis to Participate in Upcoming Investor Conferences   Business Wire
Aug 27, 2020
06:03AM EDT  HC Wainwright & Co. Initiates Coverage On Personalis with Buy Rating, Announces Price Target of $30   Benzinga
Aug 18, 2020
09:48AM EDT  Benzinga's Top Upgrades, Downgrades For August 18, 2020   Benzinga
04:58AM EDT  Needham Initiates Coverage On Personalis with Buy Rating, Announces Price Target of $25   Benzinga
Aug 12, 2020
04:01PM EDT  Personalis to Participate at the Needham Virtual Cancer Diagnostics 1x1 Conference   Business Wire
10:07AM EDT  Personalis, Inc. (PSNL) shares are declining on Wednesday morning trade.   RTTNews
05:37AM EDT  Personalis Prices 6.5M Share Public Offering of Common Stock @$19/Share   Benzinga
Aug 11, 2020
04:49PM EDT  Personalis Files For A $100M Common Stock Offering   Benzinga
Aug 7, 2020
10:07AM EDT  Morgan Stanley Maintains Overweight on Personalis, Raises Price Target to $25   Benzinga
Aug 6, 2020
04:10PM EDT  Personalis Q2 EPS $(0.29) Beats $(0.34) Estimate, Sales $19.50M Beat $16.33M Estimate   Benzinga
04:01PM EDT  Personalis Reports Second Quarter 2020 Financial Results   Business Wire
Jul 23, 2020
04:01PM EDT  Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC